00958nas a2200253   4500000000100000008004100001260001200042653001900054653002100073653001700094653002300111653002000134653001700154653002200171100001300193700001600206700001300222245005800235856007000293300001400363490000700377520030600384022001400690       2024                            d  c12/202410aDrug Discovery10aDrug repurposing10aEpidemiology10aNeglected Diseases10aPharmaceuticals10aPharmacology10aZoonotic diseases1 aMentis A1 aHernandez H1 aKaitin K00aDrug repurposing for neglected and zoonotic diseases.  uhttps://www.cell.com/action/showPdf?pii=S0165-6147%2824%2900223-2  a1100-11030 v453 a<p>Globalization and climate change have intensified the need to address the marginalization of R&D for neglected and zoonotic diseases. We propose that drug repurposing, using enabling technologies such as artificial intelligence, can address this need at a lower cost than de novo R&D processes.</p>  a1873-3735